Enanta Pharmaceuticals
ENTA
#8011
Rank
โ‚น37.97 B
Marketcap
โ‚น1,306
Share price
-0.47%
Change (1 day)
130.00%
Change (1 year)

Earnings for Enanta Pharmaceuticals (ENTA)

Earnings in 2026 (TTM): -โ‚น4.58 Billion

According to Enanta Pharmaceuticals 's latest financial reports the company's current earnings are โ‚น69.21 Million. In 2025 the company made an earning of -โ‚น6.1 Billion, an increase over its 2024 earnings that were of -โ‚น9.25 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Enanta Pharmaceuticals from 2012 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -โ‚น4.58 Billion-24.92%
2025 -โ‚น6.1 Billion-34.07%
2024 -โ‚น9.25 Billion-23.87%
2023 -โ‚น12.15 Billion4.39%
2022 -โ‚น11.64 Billion-4.4%
2021 -โ‚น12.17 Billion91.12%
2020 -โ‚น6.37 Billion-407.13%
2019 โ‚น2.07 B-78.63%
2018 โ‚น9.70 B117.97%
2017 โ‚น4.45 B-574.65%
2016 -โ‚น0.94 Billion-110.83%
2015 โ‚น8.66 B-4.5%
2014 โ‚น9.06 B-638.53%
2013 -โ‚น1.69 Billion-137.98%
2012 โ‚น4.43 B

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
โ‚น2.475 T-50,556.42%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
โ‚น1.504 T-30,755.69%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
AbbVie
ABBV
โ‚น569.35 B-11,704.65%๐Ÿ‡บ๐Ÿ‡ธ USA
Vertex Pharmaceuticals
VRTX
โ‚น482.34 B-9,931.22%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
โ‚น1.253 T-25,643.82%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
โ‚น914.49 B-18,739.29%๐Ÿ‡บ๐Ÿ‡ธ USA